Worse than lifestyle alone When directly compared, weight regain after stopping drugs was significantly faster than after stopping behavioural programmes, independent of how much weight was initially lost
Breast adenocarcinoma Prostate adenocarcinoma Non-small cell lung cancer (NSCLC) Colorectal adenocarcinoma Hepatocellular carcinoma (liver cancer) Renal cell carcinoma Pancreatic adenocarcinoma Half of the participants started a GLP-1 medication semaglutide, tirzepatide, dulaglutide, liraglutide, lixisenatide or pramlintide after their cancer diagnosis
Insurance programs, including Medicare, do not always cover weight-loss drugs, and legislation to expand Medicare coverage to include anti-obesity medications has stalled, according to a Scientific American report
There is nothing GLP-1-specific about it
Moreover, the research also focuses on developing novel GLP-1 analogs, owing to the increased demand
Conclusion In this article, we have explored semaglutide and sertraline, two medications that are widely used for different health conditions